Studying the Immunomodulatory Effects of Small Molecule Ras Inhibitors in Animal Models of Rheumatoid Arthritis
Abstract
During the first two year of the award, we made several high impact key observations:(I) Prophylactic treatment with Farnesylthiosalicylic acid (FTS), a first-in-class oral selective RAS inhibitor, provides a significant immunomodulatory effect in the rat adjuvant-induced arthritis (AIA) model by all outcome parameters(Clinical assessment and relevant laboratory/immunological/Molecular analyses). (II) Prophylactic dosing of FTS combined with methotrexate (MTX) provides a synergistic protective effect (~90 disease inhibition).(III) The FTS derivative, F-FTS, showed superior therapeutic clinical efficacy compared to FTS in the AIA model.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2016
- Accession Number
- AD1047106
Entities
People
- Einav Vax
- Galit E. Sfadia
- Itamar Goldstein
- Itzhak B. Moshe
- Itzhak Ben Moshe
- Morad Zayoud
- Yoel Kloog
Organizations
- Tel Aviv University